EcoDrugPlus

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSPEMG00000009784
Gene Symbol: IDH2
3 Cross references
261 Possible Orthologues:

Kallikrein B1

Ensembl ID : ENSPEMG00000005720
Gene Symbol: KLKB1
3 Cross references
206 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSPEMG00000022907
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSPEMG00000018642
Gene Symbol: KDR
3 Cross references
197 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSPEMG00000017786
Gene Symbol: KIF11
1 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSPEMG00000019291
Gene Symbol: KIF5B
3 Cross references
280 Possible Orthologues:

Lectin, Galactose Binding, Soluble 1

Ensembl ID : ENSPEMG00000017955
Gene Symbol: LGALS1
1 Cross references
380 Possible Orthologues:

Lectin, Galactose Binding, Soluble 3

Ensembl ID : ENSPEMG00000001219
Gene Symbol: LGALS3
1 Cross references
218 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSPEMG00000024211
Gene Symbol: LTA4H
3 Cross references
207 Possible Orthologues:

Leukotriene B4 Receptor 2

Ensembl ID : ENSPEMG00000016233
Gene Symbol: LTB4R2
3 Cross references
236 Possible Orthologues:

Lymphocyte Protein Tyrosine Kinase

Ensembl ID : ENSPEMG00000013724
Gene Symbol: LCK
1 Cross references
120 Possible Orthologues:

Lysine (K)-Specific Demethylase 1a

Ensembl ID : ENSPEMG00000019071
Gene Symbol: KDM1A
1 Cross references
213 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).